Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)
Diabetes Mellitus, Type 2
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Diabetes, Continuous Glucose Monitor, Blood Glucose, Cost-Effectiveness, Hospital, Diabetes Management, Technology, Remote Monitoring, Digital Dashboard, Cloud-Based, Hypoglycemia, Hyperglycemia, Real-Time, Clinical Decision-Making, Wireless Transmission
Eligibility Criteria
Inclusion Criteria:
- ≥ 18 years of age
- English or Spanish speaker
- ≥ one of the following: diagnosis of type 2 diabetes documented in the EMR, or use of anti-hyperglycemic agent documented in the EMR, or serum or POC glucose > 200 mg/dL in the first 24 hours of admission
Exclusion Criteria:
- Anticipated LOS < 24 hours
- Current or anticipated ICU placement
- Does not speak English or Spanish
- Known adhesive allergy
- Current participation in medication or device study
- Pregnant
- Any other condition that the PI Dr. Philis-Tsimikas or the attending physician deem contraindicated
Sites / Locations
- Scripps Whittier Diabetes Institute
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention CB CGM
Usual Care
On CB CGM patients, CGM data will also be transmitted from the bedside smartphone to the Digital Dashboard. The Digital Dashboard will integrate CGM data for CB CGM's participants for presentation via two views: (1) Real-Time Management and (2) Clinical Optimization. Telemetry technicians to conduct site-based monitoring, and the Diabetes APN will conduct remote management of patients at the site from a central, Scripps Diabetes Hub, per below. (Note, as CGMs are not FDA-approved for in-hospital glucose management, CB CGM participants will also have their glucose monitored via the hospital's standard POC testing protocol described for UC).
For UC, CGM data will be blinded to the care team and used for evaluation purposes only. Glucose will be monitored via the hospital's standard POC testing protocol (i.e., prior to meals and at bedtime for patients who are eating, and every 4-6 waking hours for patients who are not eating). Glucose management in UC is designed to minimize differences between groups, aside from CGM monitoring: UC (and intervention) participants' glucose levels will be managed using the glucose management protocol and the Diabetes APN will assess UC participants' POC data documented in the EMR from the previous 24-48 hours and make recommendations for changes to the basal/bolus regimen to improve glucose management.